Ad-hoc Announcements 2011
Here you find Ad-hoc messages of year 2011.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
|September 29, 2011|
Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint
collect (87 KB)|
|September 6, 2011|
Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban
collect (124 KB)|
Investor News issued in year 2011 can be found here.
Publications of the previous years are offered in the Archive Overview.